Pharmacy leaving no one behind…

Image Credit: Tam Nguyen

Looking into inequities ‘unmasked’ by the pandemic

The International Pharmaceutical Federation (FIP) has published its latest collection of articles on equity and equality in pharmacy.

The 2020 FIP-EquityRx Collection focuses on the inequities ‘unmasked’ by the pandemic.

“Some of those inequities are long standing ones that have not only risen to the fore but also in most cases been worsened by the pandemic,” said Dr Catherine Duggan, Chief Executive Officer of FIP and Dr Lina Bader, FIP Lead for FIP-EquityRx.

“Others, however, are an unfortunate direct consequence of COVID-19.”

Articles in the collection cover topics such as pharmacists supporting patients in lockdown with access to essential medicines; the global increase in domestic violence amid the COVID-19 health crisis; dealing with sexual harassment and navigating maternity and paternity leave; research on health inequities; the COVID-19 vaccine rollout; gender equity; and how women in science and education are at the forefront of the fight against COVID-19.

“We are very much aware we are still – unfortunately – living in the midst of the pandemic,” wrote Dr Duggan and Dr Bader in an editorial.

“We also are aware that the fallout from it, especially in regard to its impact on health equity are likely to remain for years and even decades to come… and inequities will continue to emerge, including across our profession, our societies and our communities.

“FIP-EquityRx will continue to bring to the forefront these issues affecting workforce & education, practice and science, while FIP will continue to support each of you and shine a light on practice and evidence along the way.”

EquityRx is FIP’s initiative focusing on equity, equality, gender and diversity.

Among FIP’s 21 goals, FIP Development Goal 10 (Equity & Equality) calls for clear strategies to address inequalities in the pharmaceutical workforce, widen access and equity of pharmaceutical care services and access, as well equity in global capacity in pharmaceutical sciences development.

Read the 2020 FIP-EquityRx Collection

Previous A strategic vision
Next Addressing corticosteroid phobia

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply